Blog
Alzheimer’s PREVENTION Mid-Trial Results Published
by PNI Experts
Lifestyle and Medical Management Boosts Brain Blood Flow and Reduces Diabetes Risk in Early Alzheimer’s Disease, PREVENTION Mid-Trial Findings Reveal.
The PENS Trial: Breakthrough Evidence for Treating Idiopathic Normal Pressure Hydrocephalus (iNPH)
by Zara Jethani
Results of a multi-center clinical trial for the treatment of idiopathic normal pressure hydrocephalus (iNPH) demonstrate that shunt surgery significantly improves gait and reduces falls in older adults with iNPH. This landmark study resolves decades of debate about whether shunts truly help patients. Learn more.
When Chemoradiation Can’t Wait—Treating Glioblastoma in the Face of Disaster
by Emmaline Mauritson
A patient must receive essential treatment for a brain tumor, even during an evacuation warning for the raging Pacific Palisades fire in 2025.
Glioblastoma Awareness Day: Confronting the Challenges of a Devastating Brain Tumor
by Zara Jethani
The third Wednesday of each July is Glioblastoma Awareness Day. Glioblastoma (GBM) is a complex and invasive form of brain cancer, presenting difficulties in its treatment. Learn more about GMB, clinical trials and the Cancer Moonshot.
The Role of Clinical Trials at PNI
by Guest Author
Clinical trials are research studies that play a critical role in the advancement of clinical and medical knowledge about disease. At Pacific Neuroscience Institute (PNI), there are a number of upcoming and ongoing trials for patients with various neurological conditions.
PREVENTION Trial Studies Impact of Lifestyle Changes on Alzheimer’s Risk
by Guest Author
Alzheimer’s disease is the leading cause of disability in people older than 65. The PREVENTION Trial from Providence and the Pacific Brain Health Center looks at whether healthy lifestyle changes combined with brain exercises can help prevent Alzheimer’s disease
New Drug for Lewy Body Dementia Shows Promise
by Guest Author
Drug shows encouraging signs for patients of less common type of dementia. Pacific Neuroscience Institute located at Providence Saint John’s Health Center among sites for clinical trial.
Using AI as an Early Detector of Cognitive Decline
by Zara Jethani
Pacific Neuroscience Institute’s Pacific Brain Health Center, an outpatient clinic of the Providence Saint John’s Health Center in Santa Monica, CA, is the site for an IRB approved study from Evoke Neuroscience.
Lightning Fast COVID-19 Response at Providence Saint John’s Health Center
by Zara Jethani
An antiviral and an anti-inflammatory therapy against COVID-19, and convalescent plasma are currently in clinical trials at Providence Saint John’s Health Center in Santa Monica, CA.
COVID-19 Convalescent Plasma Trial: Urgent Call For Blood Plasma Donations
by Zara Jethani
A new trial treatment using blood plasma donations from people who have fully recovered from COVID-19 infection may be helpful in treating other patients with COVID-19.
Last updated: May 5th, 2020